XIDX
MIKA
Market cap1.96bUSD
Nov 12, Last price
2,520.00IDR
Name
Mitra Keluarga Karyasehat Tbk PT
Chart & performance
P/E
25.68
P/S
6.53
EPS
98.14
Div yield, %
1.35%
Shrs. gr., 5y
-0.47%
Rev. gr., 5y
9.44%
Revenues
5.37t
+10.13%
Net income
1.36t
+19.06%
CFO
1.93t
+11.91%
Dividend
Jun 19, 202643 IDR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Mitra Keluarga Karyasehat Tbk, operating alongside its various subsidiaries, is primarily engaged in the ownership and management of hospitals across Indonesia. The company provides a comprehensive array of healthcare services, complemented by its pharmacy operations. Its extensive network includes 17 Mitra Keluarga hospitals and 9 Kasih Group hospitals, strategically situated in key Indonesian cities such as Jakarta, Bekasi, Cikarang, Depok, Cibubur, Tangerang, Sukabumi, Karawang, Cirebon, Surabaya, Cibinong, Subang, and Tegal. Established in 1989, the firm maintains its corporate headquarters in Jakarta, Indonesia, and operates as a subsidiary of PT Griyainsani Cakrasadaya.
Key people
Jozef Darmawan Angkasa
President Commissioner · since 2014
Rustiyan Oen
President Director · since 2014
Christina Anggraeni
Director · since 2024
Nurvantina Pandina
Director · since 2023
Joyce Vidyayanti Handajani
Director, Corporate Secretary · since 2019
Isje Ayusari
Commissioner · since 2022
Shinta Setiawan
Commissioner · since 2022
Johannes Setijono
Independent Commissioner · since 2020
I. Gusti Gede Subawa
Independent Commissioner · since 2014
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||